Continuous glucose monitoring in noninsulin‐treated type 2 diabetes: A critical review of reported trials with an updated systematic review and meta‐analysis of randomised controlled trials

View Full Paper

Ask AI

Bookmark

Authors

Discussion

A critical review highlights improved glycaemic outcomes in noninsulin users with T2D, suggesting CGM may enhance patient experience.

CGM use significantly reduced HbA1c by 0.37% in noninsulin-treated individuals with type 2 diabetes.
The meta-analysis included 8 RCTs with 541 total participants, 55% of whom used CGM.
CGM improved not only glycaemic outcomes but also patient experience and resource utilization.
Findings support the pragmatic recommendation of CGM in managing noninsulin-treated type 2 diabetes.

Aronson et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark